Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans

Gut

Volumn 55, Issue 8, 2006, Pages 1174-1182

  Novo, E ^a   Marra, F ^b   Zamara, E ^a   Valfre Di Bonzo L ^a   Monitillo, L ^a   Cannito, S ^a   Petrai, I ^b   Mazzocca, A ^b   Bonacchi, A ^b   De Franco, R S M ^b   Colombatto, S ^a   Autelli, R ^a   Pinzani, M ^b   Parola, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOHEXIMIDE; DOXORUBICIN; ETOPOSIDE; NERVE GROWTH FACTOR; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL LEVEL; CELL STRUCTURE; CHEMICAL ANALYSIS; DISEASE COURSE; DOSE RESPONSE; FIBROGENESIS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CIRRHOSIS; MITOCHONDRION; MOLECULAR BIOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SENESCENCE; STELLATE CELL; SURVIVAL;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE PROGRESSION; FIBROBLASTS; HUMANS; LIVER CIRRHOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746120376     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.082701     Document Type: Article

References (48)

1. Friedman SL. Liver fibrosis: from bench to bedside. J Hepatol 2003;38:S38-53.
2. Battaller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18.
3. Benyon RC, Arthur MJP. Extracellular matrix degradation and the role of hepatic stellate cells. Sem Liver Dis 2001;21:373-85.
4. Schuppan D, Ruehl M, Somasundran R, et al. Matrix as a modulator of hepatic fibrogenesis. Sem Liver Dis 2001;21:351-72.
5. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Sem Liver Dis 2001;21:397-416.
6. Ramodori G, Saile B. Mesenchymal cells in the liver-one cell type or two? Liver 2002;22:283-94.
7. Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 2002;37:527-35.
8. Cassiman D, Libbrecht L, Desmet V, et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-9.
9. Forbes SJ, Russo FP, Ray V, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004;126:955-63.
10. Iredale JP. Hepatic stellate cell behaviour during resolution of liver injury. Sem Liver Dis 2001;21:427-36.
11. Issa R, Williams E, Trim N, et al. Apoptosis of hepatic stellate cells: involvement in the resolution of of biliary fibrosis. Gut 2001;48:548-57.
12. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-49.
13. Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic stellate cells by TIMP-1 is mediated via effects on MMP-inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002;277:11069-76.
14. Elsharkawy AM, Wright MC, Hay RT, et al. Persistent activation of nuclear factor-κB in cultured hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkB family proteins. Hepatology 1999;30:761-9.
15. Saile B, Knittel T, Matthes N, et al. CD95/CD95L-mediated apoptosis of the hepatic stellate cells. Am J Pathol 1997;151:1265-72.
16. Gong WR, Pecci A, Roth S, et al. Transformation dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998;28:492-502.
17. Cariers A, Reinehr R, Fischer R, et al. c-Jun-N-termimal kinase dependent membrane targeting of CD95 in rat hepatic stellate cells. Cell Physiol Biochem 2002;12:179-86.
18. Trim N, Morgan S, Evans M, et al. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol 2000;156:1235-43.
19. Taimr O, Higuchi H, Kocova E, et al. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37:87-95.
20. Fischer R, Schmitt M, Bode JG, et al. Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology 2001;120:1212-26.
21. Fischer R, Cariers A, Reinehr R, et al. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 2002;123:845-61.
22. Wright MC, Issa R, Smart DE, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001;121:685-98.
23. Abriss B, Hollweg G, Gressner AM, et al. Adenoviral transfer of p53 or retinoblastoma protein blocks cell proliferation and induces apoptosis in culture-activated hepatic stellate cells. J Hepatol 2003;38:169-78.
24. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004;40:860-7.
25. Zamara E, Novo E, Marra F, et al. 4-Hydroxynonenal as a selective profibrogenic stimulus for activated human hepatic stellate cells. J Hepatol 2004;40:60-8.
26. Kweon YO, Paik YH, Schnabl B, et al. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 2003;39:38-46.
27. 12,14- prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. J Biol Chem 2001;276:38152-8.
28. Casini A, Pinzani M, Milani S, et al. Regulation of extracellular matrix synthesis by transforming growth factor β1 in human fat-storing cells. Gastroenterology 1993;10:245-53.
29. Failli P, De Franco RM, Caligiuri A, et al. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. Gastroenterology 2000;119:479-92.
30. Caligiuri A, De Franco RM, Romanelli RG, et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology 2003;124:504-20.
31. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-7.
32. Parola M, Robino G, Marra F, et al. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 1998;102:1942-50.
33. Robino G, Parola M, Marra F, et al. Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells. J Biol Chem 2000;275:40561-7.
34. Mazzocca A, Sciammetta SC, Carloni V, et al. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J Bid Chem 2005;280:11329-39.
35. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989;49:5870-8.
36. Smiley ST, Reers M, Mottola-Hartshorn C, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A 1991;88:3671-5.
37. Bonacchi A, Petrai I, Defranco RM, et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003;125:1060-76.
38. Pinzani M, Milani S, Herbst H, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996;148:785-800.
39. Leist M, Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nature Rev Mol Cell Biol 2001;2:1-10.
40. Bonacchi A, Taddei L, Efsen E, et al. Nuclear localization of the nerve growth factor (NGF) receptor Trk-A in liver cells. J Hepatol 2003;38(Suppl 2):P242A.
41. Charlotte F, L'Herminé A, Martin N, et al. Immunohistochemical detection of Bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144:460-5.
42. Rippe RA, Brenner DA. From quiescence to activation: gene regulation in hepatic stellate cells. Gastroenterology 2005;127:1260-2.
43. Lang A, Schoonhoven R, Tuvia S, et al. Nuclear factor kappa B in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 2000;33:49-58.
44. Schwabe RF, Brenner DA. NF-kB and PI-3 kinase/Akt differentially regulate inflammatory gene expression, but not apoptosis in activated human hepatic stellate cells. Hepatology 2001;34(Suppl 4):400A.
45. Schnabl B, Purbeck CA, Choi, YH, et al. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003;37:653-64.
46. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nature Rev Neurosci 2003;4:299-309.
47. Wang S, Bray P, McCaffrey T, et al. p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. Am J Pathol 2000;157:1247-58.
48. Cassiman D, Denef C, Desmet VJ, et al. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 2001;33:148-58.